immune system
N |
• mice do not exhibit any signs of autoimmune disease
|
• during all stages of T cell development except DN1 that does not express the cre transgene
• 10-fold in double positive cells
|
• following treatment with CpG-ODNs, mice fail to exhibit an increased in CD4+ and CD8+ single positive T cells compared with wild-type mice
• however, untreated mice exhibit normal T cell proliferation and treated mice do exhibit an increase in macrophages in the spleen and liver as in wild-type mice
|
• when stimulated with IL2
|
• however, cortical area is normal
|
• almost 3-fold
|
• in the thymus more so than single conditional knock-outs
• in the blood, lymph nodes and spleen as in Nmt1tm1.1Poru conditional knock-outs
|
• at 6 months
|
• at 2 and 6 months more so than in either single conditional knock-out
|
• CD4+ and CD8+ single positive cells at 2 and 6 months
• following treatment with CpC-ODNs, mice fail to exhibit an increased in CD4+ and CD8+ single positive T cells compared with wild-type mice
|
• CD4+ T cells isolated from the lymph nodes and spleen exhibit a shift from naive to activated/memory phenotypes
|
• CD8+ T cells isolated from the lymph nodes and spleen exhibit a shift from naive to activated/memory phenotypes
|
• in mice sensitized with D-galactosamine hydrochloride and treated with staphylococcal enterotoxin B
|
• in mice sensitized with D-galactosamine hydrochloride and treated with staphylococcal enterotoxin B
|
• in mice sensitized with D-galactosamine hydrochloride and treated with staphylococcal enterotoxin B
|
• after TCR-independent activation
|
• after TCR-independent activation
|
• mice sensitized with D-galactosamine hydrochloride and treated with staphylococcal enterotoxin B exhibit reduced plasma levels of TNF, IL2 and IFN-gamma compared with wild-type mice
|
homeostasis/metabolism
• in mice sensitized with D-galactosamine hydrochloride and treated with staphylococcal enterotoxin B
|
• in mice sensitized with D-galactosamine hydrochloride and treated with staphylococcal enterotoxin B
|
• in mice sensitized with D-galactosamine hydrochloride and treated with staphylococcal enterotoxin B
|
cellular
• during all stages of T cell development except DN1 that does not express the cre transgene
• 10-fold in double positive cells
|
• following treatment with CpG-ODNs, mice fail to exhibit an increased in CD4+ and CD8+ single positive T cells compared with wild-type mice
• however, untreated mice exhibit normal T cell proliferation and treated mice do exhibit an increase in macrophages in the spleen and liver as in wild-type mice
|
• when stimulated with IL2
|
endocrine/exocrine glands
• however, cortical area is normal
|
• at 6 months
|
hematopoietic system
• during all stages of T cell development except DN1 that does not express the cre transgene
• 10-fold in double positive cells
|
• following treatment with CpG-ODNs, mice fail to exhibit an increased in CD4+ and CD8+ single positive T cells compared with wild-type mice
• however, untreated mice exhibit normal T cell proliferation and treated mice do exhibit an increase in macrophages in the spleen and liver as in wild-type mice
|
• when stimulated with IL2
|
• however, cortical area is normal
|
• almost 3-fold
|
• in the thymus more so than single conditional knock-outs
• in the blood, lymph nodes and spleen as in Nmt1tm1.1Poru conditional knock-outs
|
• at 6 months
|
• at 2 and 6 months more so than in either single conditional knock-out
|
• CD4+ and CD8+ single positive cells at 2 and 6 months
• following treatment with CpC-ODNs, mice fail to exhibit an increased in CD4+ and CD8+ single positive T cells compared with wild-type mice
|
• CD4+ T cells isolated from the lymph nodes and spleen exhibit a shift from naive to activated/memory phenotypes
|
• CD8+ T cells isolated from the lymph nodes and spleen exhibit a shift from naive to activated/memory phenotypes
|